Getting Rihanna’s number, Merck’s Big Drug Deal
Good day for unlisted numbers, Bad day for alternative medicines
GOOD DAY FOR: Unlisted numbers, after the entertainment program Extra published the cellphone numbers of singers Rihanna and Chris Brown. The numbers were printed on court documents that the program put up on screen and, apparently, forgot to blur out. (The Inquisitr)
BAD DAY FOR: Alternative medicines, after U.S. pharmaceutical giant Merck agreed to buy rival Schering-Plough for $41.1 billion, making Merck the second-largest U.S. drugmaker, after Pfizer. Earlier this year, Pfizer offered $62 billion for drugmaker Wyeth. “It clearly is a year of mergers for pharmaceutical companies,” said Natixis Securities analyst Philippe Lanone. (Bloomberg)
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Death from above: Drones upend rules of war in Ukraine
Feature The world's militaries are paying close attention to drone use in the Russia-Ukraine war
-
Supreme Court: Ceding more power to Trump?
Feature SCOTUS has given Trump a victory by ending nationwide injunctions, limiting judges' power to block presidential orders
-
What is Linda Yaccarino's legacy? And what's next for X?
Today's Big Question An 'uncertain future' in the age of TikTok